✦ LIBER ✦

CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: A randomized clinical trial

✍ Scribed by Hagberg, H.; Björkholm, M.; Glimelius, B.; Lindemalm, Ch.; Mellstedt, H.; Killander, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of CHOP-B vs CEOP-B in ‘poor

✍ De Lena, Mario ;Maiello, Evaristo ;Lorusso, Vito ;Brandi, Mario ;Calabrese, Pier 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 501 KB

CHOP vs. ProMACE-CytaBOM in the treatmen

✍ E. Montserrat; J. García-Conde; N. Viñolas; A. López-Guillermo; L. Hernández-Nie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Non-hodgkin's lymphoma of unfavourable h

✍ Arturo Pereira; Francisco Cervantes; Emilio Montserrat; Carlos Llebaria; Ciril R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

Clinical randomized comparative trial of

✍ Wenwu Wang; Xuenong OuYang; Zhangshu Cheng; Yonghai Peng; Fangwei Xie; Zongyang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 169 KB

Rituximab in the treatment of non-Hodgki

✍ Griffin, Morag Meriel; Morley, Nick 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 248 KB

SEOM clinical guidelines for the treatme

✍ Delvys Rodríguez-Abreu; Marta Llanos Muñoz; Mariano Provencio Pulla; Antonio Rue 📂 Article 📅 2010 🏛 Springer Milan 🌐 Spanish ⚖ 278 KB